Updated:
SMERemediumCap
SMERemediumCap is a corporate mid-market turnaround fund focused on the Greek market. It addresses the equity and liquidity funding gap in mid-market corporate...
SMERemediumCap
SMERemediumCap is a corporate mid-market turnaround fund focused on the Greek market. It addresses the equity and liquidity funding gap in mid-market corporate restructurings. The fund provides strategic and management skills support.
General information
Firm type
Private Equity
Year founded
2020
AUM
Undisclosed
Location
Region
Europe
Country
Cyprus
City
Nicosia
Corporate office
6 Emmanouil Roidi, Third Floor, Office 5, 1094 Nicosia, Cyprus
Frequently asked questions
What is SMERemediumCap's regulatory status?
SMERemediumCap Ltd is an authorised Alternative Investment Fund Manager under Cyprus law, the EU transposition of the AIFMD. This license allows the firm to manage and market alternative investment funds to professional investors across European Economic Area member states, with governance, risk management, and reporting obligations codified by the directive.
Does the firm invest directly or through fund structures?
The firm provides management services to EU-licensed alternative investment funds. Its own materials describe structuring bespoke vehicles rather than operating a proprietary balance-sheet investment program. The underlying funds pursue buyout, growth, recapitalisation, restructuring, turnaround, and venture strategies.
What investment stages does SMERemediumCap target?
The stated strategy covers both mature-company situations — buyouts, growth equity injections, recapitalisations, restructurings, and turnarounds — and general venture. No stage-specific minimum or maximum investment size has been published.
Has SMERemediumCap disclosed any limited partners or capital sources?
No. The firm has not publicly identified the investors in the funds it manages, nor has it disclosed a figure for assets under management or capital deployed.
How is the firm's governance structured to avoid conflicts of interest?
SMERemediumCap states it takes all reasonable steps to avoid conflicts of interest and operates under high standards of integrity, transparency, and confidentiality. The AIFMD regime under which it is licensed imposes statutory conflict-of-interest identification, disclosure, and mitigation requirements, but the firm has not published a detailed conflicts policy.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: